Technical Analysis for TSVT - 2seventy bio, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
50 DMA Resistance | Bearish | 2.96% | |
Crossed Above 20 DMA | Bullish | 2.96% | |
MACD Bullish Signal Line Cross | Bullish | 2.96% | |
Bollinger Band Squeeze | Range Contraction | 2.96% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 14 hours ago |
Up 5% | about 14 hours ago |
Gap Up Partially Closed | about 15 hours ago |
50 DMA Support | about 15 hours ago |
Rose Above Previous Day's High | about 15 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.69 |
52 Week Low | 1.535 |
Average Volume | 1,158,777 |
200-Day Moving Average | 4.26 |
50-Day Moving Average | 4.81 |
20-Day Moving Average | 4.60 |
10-Day Moving Average | 4.70 |
Average True Range | 0.38 |
RSI (14) | 53.05 |
ADX | 13.58 |
+DI | 26.28 |
-DI | 24.64 |
Chandelier Exit (Long, 3 ATRs) | 4.06 |
Chandelier Exit (Short, 3 ATRs) | 4.58 |
Upper Bollinger Bands | 5.03 |
Lower Bollinger Band | 4.17 |
Percent B (%b) | 0.82 |
BandWidth | 18.61 |
MACD Line | -0.06 |
MACD Signal Line | -0.09 |
MACD Histogram | 0.0254 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.29 | ||||
Resistance 3 (R3) | 5.30 | 5.16 | 5.22 | ||
Resistance 2 (R2) | 5.16 | 5.06 | 5.16 | 5.20 | |
Resistance 1 (R1) | 5.02 | 4.99 | 5.09 | 5.01 | 5.17 |
Pivot Point | 4.88 | 4.88 | 4.92 | 4.88 | 4.88 |
Support 1 (S1) | 4.74 | 4.78 | 4.81 | 4.73 | 4.57 |
Support 2 (S2) | 4.60 | 4.71 | 4.60 | 4.54 | |
Support 3 (S3) | 4.46 | 4.60 | 4.52 | ||
Support 4 (S4) | 4.45 |